Jaguar Health (JAGX) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2026)
Jaguar Health (JAGX) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Jaguar Health |
1.44 Mn |
-10.19 Mn |
19.11 Mn |
97.67% |
| Date | Value |
|---|
| Mar 31, 2026 |
97.67% |
| Dec 31, 2025 |
-101.80% |
| Sep 30, 2025 |
76.11% |
| Jun 30, 2025 |
-285.71% |
| Mar 31, 2025 |
-570.86% |
| Dec 31, 2024 |
100.79% |
| Sep 30, 2024 |
-16.84% |
| Jun 30, 2024 |
93.57% |
| Mar 31, 2024 |
-3,545.19% |
| Dec 31, 2023 |
-578,663.64% |
| Sep 30, 2023 |
-154.81% |
| Jun 30, 2023 |
-371.49% |
| Mar 31, 2023 |
89.65% |
| Dec 31, 2022 |
100.50% |
| Sep 30, 2022 |
-3,170.37% |
| Jun 30, 2022 |
-2,729.03% |
| Mar 31, 2022 |
-8,150.00% |
| Dec 31, 2021 |
-97,155.56% |
| Sep 30, 2021 |
56.45% |
| Jun 30, 2021 |
29.55% |
